Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Wood Group extends Sidara offer deadline for second time

(Sharecast News) - Scottish engineering and consulting business Wood Group has extended the deadline for Dubai's Sidara to make a formal takeover offer for the second time. The company announced that it would be pushing the so-called 'put up or shut up' deadline, due to expire on Thursday, by another month.

Sidara, formally known as Dar Al-Handasah Consultants Shair and Partners Holdings, now has until 15 May to either announce a firm intention to make an offer for Wood Group or walk away.

"There can be no certainty that an offer will be made even if the pre-conditions are satisfied or waived," Wood Group said on Thursday.

This is the second extension of the PUSU deadline following the initial approach received from Sidara in February, when the latter made a non-binding proposal of 35p per share, valuing the company at £242m. Sidara also said it would inject $450m into the business as part of a potential deal, but was still undergoing due diligence before making a formal offer.

"Work continues on a range of alternative refinancing options to provide the company with an appropriate and sustainable long-term capital structure. Having carefully considered the viability of these options together with its financial advisers, the board of Wood currently believes that the possible offer represents the better option for Wood's shareholders, creditors and other stakeholders," Wood Group said in an update last week.

Sidara first approached Wood Group last year, but talks collapsed in the summer "in light of rising geopolitical risks and financial market uncertainty", as both parties failed to agree on terms.

Wood Group's shares are likely to be suspended from trade from 30 April as the company delays its full-year results "in light of extensive work needed to conclude its audit for FY24".

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.